Skip to main content

Advertisement

SpringerLink
Log in

Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Owens RC Jr, Ambrose PG (2005) Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis 41:S144–S157

    Article  PubMed  CAS  Google Scholar 

  2. Mehlhorn AJ, Brown DA (2007) Safety concerns with fluoroquinolones. Ann Pharmacother 41:1859–1866

    Article  PubMed  Google Scholar 

  3. Bellon A, Perez-Garcia G, Coverdale JH, Chacko RC (2009) Seizures associated with levofloxacin: case presentation and literature review. Eur J Clin Pharmacol 65:959–962

    Article  PubMed  CAS  Google Scholar 

  4. Yamaguchi H, Kawai H, Matsumoto T, Yokoyama H, Nakayasu T, Komiya M, Shimada J (2007) Post-marketing surveillance of the safety of levofloxacin in Japan. Chemotherapy 53:85–103

    Article  PubMed  CAS  Google Scholar 

  5. Miller AD, Ball AM, Bookstaver PB, Dornblaser EK, Bennett CL (2011) Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy 31:408–423

    Article  PubMed  CAS  Google Scholar 

  6. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245

    Article  PubMed  CAS  Google Scholar 

  7. Kushner JM, Peckman HJ, Snyder CR (2001) Seizures associated with fluoroquinolones. Ann Pharmacother 35:1194–1198

    Article  PubMed  CAS  Google Scholar 

  8. Stahlmann R, Lode H (2010) Safety considerations of fluoroquinolones in the elderly: an update. Drugs Aging 27:193–209

    Article  PubMed  Google Scholar 

  9. Maeda T, Takahashi K, Ohtsu N, Oguma T, Ohnishi T, Atsumi R, Tamai I (2007) Identification of influx transporter for the quinolone antibacterial agent levofloxacin. Mol Pharm 4:85–94

    Article  PubMed  CAS  Google Scholar 

  10. Franke RM, Scherkenbach LA, Sparreboom A (2009) Pharmacogenetics of the organic anion transporting polypeptide 1A2. Pharmacogenomics 10:339–344

    Article  PubMed  CAS  Google Scholar 

  11. Löscher W, Potschka H (2005) Blood–brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2:86–98

    Article  PubMed  Google Scholar 

  12. Robey RW, Polgar O, Deeken J, To KW, Bates SE (2007) ABCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev 26:39–57

    Article  PubMed  CAS  Google Scholar 

  13. Sakurai A, Tamura A, Onishi Y, Ishikawa T (2005) Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications. Expert Opin Pharmacother 6:2455–2473

    Article  PubMed  CAS  Google Scholar 

  14. Kroetz DL, Pauli-Magnus C, Hodges LM, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, DeYoung J, Taylor T, Carlson EJ, Herskowitz I, Giacomini KM, Clark AG (2003) Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics 13:481–494

    Article  PubMed  CAS  Google Scholar 

  15. Erdilyi DJ, Kámory E, Csókay B, Andrikovics H, Tordai A, Kiss C, Filni-Semsei A, Janszky I, Zalka A, Fekete G, Falus A, Kovács GT, Szalai C (2008) Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy. Pharmacogenomics J 8:321–327

    Article  PubMed  CAS  Google Scholar 

  16. Agarwal S, Elmquist WF (2012) Insight into the cooperation of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) at the blood–brain barrier: a case study examining sorafenib efflux clearance. Mol Pharm 9:678–684

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

  1. III Division of Infectious Diseases, L. Sacco University Hospital, Via GB Grassi 74, 20157, Milan, Italy

    Cristina Gervasoni, Laura Milazzo & Agostino Riva

  2. Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy

    Dario Cattaneo, Felicia Stefania Falvella & Stefania Cheli

  3. Department of Infectious Diseases, Busto Arsizio Hospital, Busto Arsizio, Italy

    Paola Vitiello

  4. Department of Biomedical and Clinical Sciences, Clinical Pharmacology Unit, Consiglio Nazionale delle Ricerche Institute of Neuroscience, L. Sacco University Hospital, Università degli Studi di Milano, Milan, Italy

    Emilio Clementi

  5. E. Medea Scientific Institute, Bosisio Parini, Italy

    Emilio Clementi

Authors
  1. Cristina Gervasoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dario Cattaneo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Felicia Stefania Falvella
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paola Vitiello
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stefania Cheli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Laura Milazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Emilio Clementi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Agostino Riva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cristina Gervasoni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gervasoni, C., Cattaneo, D., Falvella, F.S. et al. Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics. Eur J Clin Pharmacol 69, 1611–1613 (2013). https://doi.org/10.1007/s00228-013-1515-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-013-1515-7

Keywords

Search

Navigation